Gut Microbiota Regulates Brain–Bone Axis to Influence Osteoporosis Pathogenesis and Treatment
Top Cited Papers
Open Access
- 1 January 2026
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Research
- Vol. 9
Abstract
Osteoporosis is a systemic skeletal disorder characterized by reduced bone mass, impaired microarchitecture, and increased fracture risk, primarily resulting from dysregulated bone remodeling. Increasing evidence highlights a close interaction between bone metabolism and the gut microbiota. Alterations in bone mineral density can influence gut microbial composition. Conversely, microbial dysbiosis disrupts bone homeostasis through multiple pathways, including microbial metabolites, immune regulation, and neuroendocrine signaling. Short-chain fatty acids suppress osteoclast differentiation and enhance intestinal calcium absorption, while gut dysbiosis promotes bone loss by impairing intestinal barrier integrity and increasing proinflammatory cytokines such as tumor necrosis factor-α and interleukin-6. The gut–brain–bone axis represents an important regulatory network linking the central nervous system, gut-derived signals, and skeletal remodeling. Chronic stress and neurodegenerative conditions activate the hypothalamic–pituitary–adrenal axis and bone-derived extracellular vesicle signaling, thereby favoring bone resorption. Estrogen deficiency further disrupts the receptor activator of nuclear factor κΒ ligand/osteoprotegerin signaling pathway and alters gut microbial composition, contributing to postmenopausal bone loss. Therapeutic strategies targeting this axis, including probiotics, prebiotics, fecal microbiota transplantation, dietary fiber supplementation, and pharmacological or natural compounds, show potential in restoring microbial balance and improving bone metabolism. Future studies integrating multiomics approaches and well-designed clinical trials are needed to clarify microbiome–bone interactions and support the development of targeted interventions for osteoporosis.Keywords
Funding Information
- National Natural Science Foundation of China (82101956)
- Science and Technology Development Fund, Macau SAR (file No.0114/2022/A 0018/2024/RIA1)
- High Level Key Discipline Construction Project of the State Administration of Traditional Chinese Medicine (zyyzdxk-2023123)
- Integration Development Strategy Project of Jinan City and College (JNSX2024046)
- clinical-basic joint innovation team project of Shandong First Medical University (CX202408)
- Natural Science Foundation of Shandong Province (ZR2024MH189)
- University Youth Innovation Team of Shandong Province (2023KJ176)
- Young Talent of Lifting engineering for Science and Technology in Shandong (SDAST2024QTA044)
- Shandong Province Traditional Chinese Medicine Science and Technology Project (M-2023106, M-2022253)
- Medicine and Health Science and Technology Project of Shandong Province (202404070291)
- Qingchuang Talents Induction Program of Shandong Higher Education Institution (2024Y08)
- Cultivating Plan Program for the Leader in Science and Technology of Yunnan Province (25110100011)
This publication has 95 references indexed in Scilit:
- Serotonin in the gut: Blessing or a curseBiochimie, 2019
- What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and DiseasesMicroorganisms, 2019
- Side effects of drugs for osteoporosis and metastatic bone diseaseBritish Journal of Clinical Pharmacology, 2018
- Lactobacillus acidophilus inhibits bone loss and increases bone heterogeneity in osteoporotic mice via modulating Treg-Th17 cell balanceBone Reports, 2018
- Short-chain fatty acids regulate systemic bone mass and protect from pathological bone lossNature Communications, 2018
- Estrogen Regulates Bone Turnover by Targeting RANKL Expression in Bone Lining CellsScientific Reports, 2017
- Commensal Gut Microbiota Immunomodulatory Actions in Bone Marrow and Liver have Catabolic Effects on Skeletal Homeostasis in HealthScientific Reports, 2017
- Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis?Journal of Atherosclerosis and Thrombosis, 2017
- Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin BiosynthesisCell, 2015
- The two faces of serotonin in bone biologyJournal of Cell Biology, 2010